Sponsor Pipeline

Grupo Español Multidisciplinar de Melanoma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06906822 PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients Melanoma Recruiting
NCT06887088 Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF… Melanoma BRAF V600E/K Mutated Recruiting
NCT07057596 Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma Mestastatic Uveal Melanoma Recruiting
Not specified
NCT03605771 Descriptive Observational Study on the Characteristics of Advanced and Metastatic… Melanoma Stage Iv Recruiting
Disease Areas
Get alerts when Grupo Español Multidisciplinar de Melanoma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free